Online citations, reference lists, and bibliographies.
← Back to Search

Recent Progress In Tumor PH Targeting Nanotechnology.

E. Lee, Zhonggao Gao, Y. Bae
Published 2008 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
pH-sensitive polymeric micelles and nanogels have recently been developed to target slightly acidic extracellular pH environment of solid tumors. The pH targeting approach is regarded as a more general strategy than conventional specific tumor cell surface targeting approaches, because the acidic tumor microclimate is most common in solid tumors. When nanosystems are combined with triggered release mechanisms by endosomal or lysosomal acidity plus endosomolytic capability, the nanocarriers demonstrated to overcome multidrug resistance of various tumors. This review highlights recent progress of the pH-sensitive nanotechnology developed in Bae research group.
This paper references
10.1016/J.JCONREL.2007.04.011
Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
E. Kajiwara (2007)
10.1016/S0169-409X(01)00245-9
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.
S. Vinogradov (2002)
10.1016/J.IJPHARM.2006.12.002
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
A. Cirstoiu-Hapca (2007)
10.1097/00001813-200401000-00002
Relevance of tumor microenvironment for progression, therapy and drug development.
T. Henning (2004)
10.1016/S0005-2736(01)00389-3
On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes.
S. Simões (2001)
10.3727/000000003108748603
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008.
B. D. Lee (2003)
10.1038/nrc1611
Ovarian Cancer Metastasis: Integrating insights from disparate model organisms
H. Naora (2005)
Acid pH in tumors and its potential for therapeutic exploitation.
I. Tannock (1989)
10.1016/S1461-5347(99)00211-4
Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway?
Duncan (1999)
10.1056/NEJM199405053301802
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
H. Muss (1994)
10.1111/j.1745-7254.2007.00565.x
FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo
W. Deng (2007)
10.1016/S0163-7827(00)00011-4
Current status of pH-sensitive liposomes in drug delivery.
D. Drummond (2000)
10.1210/ENDO.135.5.7956924
Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.
S. S. Chaidarun (1994)
10.1016/S1359-6446(98)01276-8
Role of organelle pH in tumor cell biology and drug resistance.
V. Simon (1999)
10.1093/JNCI/DJM043
Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
N. Rapoport (2007)
10.1211/0022357044364
Reversal of cancer multidrug resistance by green tea polyphenols
Yuying Mei (2004)
10.1016/J.JCONREL.2005.01.006
Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
Sun Hwa Kim (2005)
10.1016/J.VIROL.2006.12.014
Human immunodeficiency virus-like particles activate multiple types of immune cells.
G. Sailaja (2007)
10.1038/nrc1387
Insulin-like growth factors and neoplasia
M. Pollak (2004)
10.1016/J.JCONREL.2007.07.012
Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Jinyoung Ko (2007)
10.1016/J.ADDR.2006.09.020
Thermo- and pH-responsive polymers in drug delivery.
D. Schmaljohann (2006)
10.1016/S0168-3659(03)00205-0
Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization.
E. Lee (2003)
10.1016/j.ijpharm.2008.03.003
L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity.
K. Oh (2008)
10.1016/j.jconrel.2007.11.014
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles.
Haiqing Yin (2008)
10.1158/1535-7163.MCT-07-2005
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance–linked ABCG2 transporter
Chung-Pu Wu (2007)
10.1016/S0168-3659(03)00239-6
Polymeric micelle for tumor pH and folate-mediated targeting.
E. Lee (2003)
10.1016/0360-3016(94)90114-7
Human tumor extracellular pH as a function of blood glucose concentration.
D. Leeper (1994)
10.1124/jpet.106.101154
A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System
H. L. Wong (2006)
10.1016/J.JCONREL.2005.06.002
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.
S. Vinogradov (2005)
10.1006/BBRC.1998.9460
Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking.
R. Tachibana (1998)
10.1158/0008-5472.CAN-06-1648
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
Lilian E van Vlerken (2007)
10.1177/153303460500400605
Long-Circulating Polymeric Nanovectors for Tumor-Selective Gene Delivery
S. Kommareddy (2005)
10.1093/JNCI/92.16.1295
A family of drug transporters: the multidrug resistance-associated proteins.
P. Borst (2000)
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.
M. A. Izquierdo (1996)
10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K
Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes
A. Ojugo (1999)
10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z
In vivo imaging of extracellular pH using 1H MRSI
R. van Sluis (1999)
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
J. Wu (2007)
10.1002/cncr.10630
Changing patient perceptions of the side effects of cancer chemotherapy
N. Carelle (2002)
10.1002/ANIE.200250653
Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change.
Y. Bae (2003)
10.1038/bjc.1998.289
The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase.
M. Yamagata (1998)
10.1002/MABI.200500121
pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media.
G. M. Kim (2005)
10.1073/PNAS.91.3.1128
Intracellular pH and the control of multidrug resistance.
S. Simon (1994)
10.1152/AJPREGU.1984.246.4.R409
Metabolic regulation via intracellular pH.
W. Busa (1984)
10.1111/j.1745-7254.2005.00216.x
Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles
M. Huang (2005)
10.1039/B706973A
Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels
Motoi Oishi (2007)
10.1038/sj.cr.7290311
Expression of TRAIL and TRAIL receptors in normal and malignant tissues
R. A. Daniels (2005)
10.3109/02656739509022457
Extracellular pH distribution in human tumours.
K. Engin (1995)
10.1517/13543784.16.8.1227
Novel agents in ovarian cancer
D. Matei (2007)
10.1021/NL0479987
Super pH-sensitive multifunctional polymeric micelle.
E. Lee (2005)
10.1038/nature05630
Multiple molecular mechanisms for multidrug resistance transporters
C. Higgins (2007)
10.1016/J.IJPHARM.2006.12.033
Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
Yongzhong Wang (2007)
10.1177/002215549804601205
Confocal Scanning Microspectrofluorometry Reveals Specific Anthracyline Accumulation in Cytoplasmic Organelles of Multidrug-resistant Cancer Cells
R. Belhoussine (1998)
10.1002/(SICI)1097-0215(19960117)65:2<230::AID-IJC17>3.0.CO;2-H
Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines
M. A. Izquierdo (1996)
10.1073/PNAS.86.12.4525
Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblasts.
M. Schwartz (1989)
10.1039/B707142F
Polymeric nanovehicles for anticancer drugs with triggering release mechanisms
K. Oh (2007)
10.1016/S1357-4310(99)01615-9
Causes and consequences of tumour acidity and implications for treatment.
M. Stubbs (2000)
10.3727/0965040041292378
Screening novel, potent multidrug-resistant modulators from imidazole derivatives.
L. Chen (2004)
10.1016/J.ADDR.2007.04.008
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
H. L. Wong (2007)
10.1073/PNAS.96.20.11531
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
N. Scholler (1999)
10.1007/s004240050829
P-glycoprotein inhibition by glibenclamide and related compounds
P. Golstein (1999)
10.1016/S0168-3659(02)00017-2
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations.
Guangfeng Shi (2002)
10.1016/J.BIOMATERIALS.2007.10.004
Biotinylated thermoresponsive micelle self-assembled from double-hydrophilic block copolymer for drug delivery and tumor target.
Cheng Cheng (2008)
Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.
K. Shain (2001)
10.1080/02656730600582956
Hyperthermia mediated liposomal drug delivery
A. M. Ponce (2006)
10.1158/0008-5472.CAN-05-4199
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
D. Kirpotin (2006)
10.1016/J.DRUDIS.2006.07.005
Exploiting the enhanced permeability and retention effect for tumor targeting.
A. Iyer (2006)
10.1016/J.IJPHARM.2006.03.045
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
M. Chavanpatil (2006)
10.1038/bjc.1993.375
pH in human tumour xenografts: effect of intravenous administration of glucose.
T. Volk (1993)
10.1016/J.AB.2004.12.026
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.
N. Parker (2005)
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
K. Miyake (1999)
10.3816/CBC.2007.N.035
The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies.
T. Fojo (2007)
10.1007/978-0-387-74039-3_1
Overview of resistance to systemic therapy in patients with breast cancer.
A. González-Angulo (2007)
10.1093/ANNONC/MDI396
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.
R. Advani (2005)
10.1016/J.YMETH.2006.05.024
Virus-like particles: designing an effective AIDS vaccine.
Kelly R. Young (2006)
10.1002/smll.200701275
Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.
D. Kim (2008)
10.1007/s00259-006-0118-2
In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer
C. Müller (2006)
10.1016/S0169-409X(99)00035-6
Cytosolic drug delivery using pH- and light-sensitive liposomes.
Gerasimov (1999)
10.1023/A:1013108524062
The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance
L. Mayer (2004)
The pharmacology of cancer resistance.
R. O'Connor (2007)
10.1016/S0142-9612(99)00125-8
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
C. E. Soma (2000)
10.1002/ADFM.200601188
pH-tunable endosomolytic oligomers for enhanced nucleic acid delivery
H. Kang (2007)
10.1038/nm0695-578
The drug resistance-related protein LRP is the human major vault protein
G. Scheffer (1995)
10.1002/JPS.20813
Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.
S. Kommareddy (2007)
10.1007/s11095-007-9277-5
Enhanced Intercellular Retention Activity of Novel pH-sensitive Polymeric Micelles in Wild and Multidrug Resistant MCF-7 Cells
Ghazal Mohajer (2007)
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
A. Chaudhry (1999)
10.1002/1097-0142(19950901)76:5<916::aid-cncr2820760531>3.0.co;2-v
Peripheral neurotoxicity of taxol in patients previously treated with cisplatin
Ajay Anand (1995)
10.1038/nrc1609
ERBB receptors and cancer: the complexity of targeted inhibitors
N. Hynes (2005)
10.1073/PNAS.95.26.15665
A multidrug resistance transporter from human MCF-7 breast cancer cells.
L. Doyle (1998)
10.1016/S0005-2736(01)00376-5
The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.
S. Stolnik (2001)
10.1023/A:1018942823676
Fundamental Relationships Between the Composition of Pluronic Block Copolymers and Their Hypersensitization Effect in MDR Cancer Cells
E. Batrakova (2004)
10.1016/j.jconrel.2008.04.024
Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.
E. Lee (2008)
10.1016/J.JCONREL.2004.12.018
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
E. Lee (2005)
10.1016/J.JCONREL.2006.12.008
TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.
V. Sethuraman (2007)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I1.10
Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers.
A. Kabanov (2002)
Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
F. Wang (2000)
10.1007/BF00877238
In vitro andin vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative
A. Pierré (2004)
10.1016/J.IJPHARM.2006.08.039
Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
T. Kobayashi (2007)
10.1073/PNAS.95.8.4607
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
10.1080/10611860500376741
Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice
Z. Gao (2005)
10.1002/anie.200704121
A virus-mimetic nanogel vehicle.
E. Lee (2008)
Cellular mechanisms of multidrug resistance of tumor cells.
A. Stavrovskaya (2000)
10.1016/J.EJPB.2006.11.010
In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration.
J. Liu (2007)



This paper is referenced by
10.1002/cphc.201001050
Molecular tweezers: concepts and applications.
J. Leblond (2011)
10.1021/acs.chemrev.8b00199
Block Copolymer Micelles in Nanomedicine Applications.
H. Cabral (2018)
10.1063/1.3207275
Comparison of a hydrogel model to the Poisson-Boltzmann cell model.
G. Claudio (2009)
10.1016/j.jconrel.2011.02.029
Multi-responsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs.
Zeng-Ying Qiao (2011)
Polyelectrolyte Complexes Based on Poly(acrylic acid): Mechanics and Applications
X. Lu (2018)
10.1039/c8cs00806j
Molecular engineering of polymeric supra-amphiphiles.
Yincheng Chang (2019)
10.1002/cmdc.201900335
Efficacious Doxorubicin Delivery Using Glutathione‐Responsive Hollow Non‐phospholipid Vesicles Bearing Lipoyl Cholesterols
K. Kumar (2019)
10.1002/asia.201500847
Thermo/pH Dual Responsive Mixed-Shell Polymeric Micelles Based on the Complementary Multiple Hydrogen Bonds for Drug Delivery.
Q. Wu (2016)
10.1016/J.JKSUS.2017.10.004
Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: A review
I. Venditti (2017)
10.2147/IJN.S86053
pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells
H. Chen (2015)
10.3390/nano5042019
Recent Advance on Mesoporous Silica Nanoparticles-Based Controlled Release System: Intelligent Switches Open up New Horizon
R. Sun (2015)
10.1016/j.ijpharm.2017.11.003
Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: A review.
Z. Wang (2018)
10.1021/cr5004634
Mechanisms of drug release in nanotherapeutic delivery systems.
Pamela T Wong (2015)
10.7717/peerj.3429
Design of new acid-activated cell-penetrating peptides for tumor drug delivery
J. Yao (2017)
10.1002/cbin.11037
Preparation and investigation of indirubin‐loaded SLN nanoparticles and their anti‐cancer effects on human glioblastoma U87MG cells
A. Rahiminejad (2019)
10.1517/17425247.2012.665365
Recent trends in cancer drug resistance reversal strategies using nanoparticles
S. Palakurthi (2012)
10.1021/la304872d
One-pot, exchange-free, room-temperature synthesis of sub-10 nm aqueous, noninteracting, and stable zwitterated iron oxide nanoparticles.
Zaki G. Estephan (2013)
Folic acid conjugated chitosan-based Mn(2+)-doped ZnS quantum dot for breast cancer cell imaging and targeted drug delivery
I. Bwatanglang (2017)
10.1002/mabi.201700372
Glucose-Responsive Trehalose Hydrogel for Insulin Stabilization and Delivery.
J. Lee (2018)
10.1016/j.ijbiomac.2018.12.178
Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment.
T. Li (2019)
10.1038/ncomms8787
Residue-specific structures and membrane locations of pH-low insertion peptide by solid-state nuclear magnetic resonance
Nicolas S. Shu (2015)
10.2217/fon.15.91
Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.
S. Friberg (2015)
10.1155/2014/926268
Use of Novel Polyurethane Microspheres in a Curcumin Delivery System
Yongmei Hu (2014)
10.2174/187221009789177803
Polymeric nano-assemblies as emerging delivery carriers for therapeutic applications: a review of recent patents.
J. Zhang (2009)
10.1016/j.biomaterials.2012.12.038
The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles.
C. Liu (2013)
10.1081/E-EBPP-120050564
Liposomal Membrane Modification, Polymers for
Madhura Deshpande (2015)
10.1016/j.carbpol.2019.115511
Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity.
M. Alle (2020)
10.1016/j.msec.2019.110159
Reactive oxygen species-responsive amino acid-based polymeric nanovehicles for tumor-selective anticancer drug delivery.
Y. Yuan (2020)
10.1002/9780470875780.CH14
Endolysosomolytically Active pH‐Sensitive Polymeric Nanotechnology
H. Kang (2010)
10.1039/c9ra09923a
A siramesine-loaded metal organic framework nanoplatform for overcoming multidrug resistance with efficient cancer cell targeting
Jiahui Liu (2020)
10.1159/000371345
Dialysate Lavage: An Alternative Solution for Reducing the Peritoneal Implantation of Poorly Differentiated Gastric Cancer Cells
Shin-Yun Liu (2015)
10.1007/978-94-017-8739-0_11
Nanomedicine: the promise and challenges in cancer chemotherapy.
Youssef W. Naguib (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar